Luyan PharmaLtd Balance Sheet Health
Financial Health criteria checks 5/6
Luyan PharmaLtd has a total shareholder equity of CN¥3.0B and total debt of CN¥4.9B, which brings its debt-to-equity ratio to 162.3%. Its total assets and total liabilities are CN¥12.0B and CN¥9.0B respectively. Luyan PharmaLtd's EBIT is CN¥695.4M making its interest coverage ratio 3.2. It has cash and short-term investments of CN¥458.1M.
Key information
162.3%
Debt to equity ratio
CN¥4.94b
Debt
Interest coverage ratio | 3.2x |
Cash | CN¥458.14m |
Equity | CN¥3.04b |
Total liabilities | CN¥8.98b |
Total assets | CN¥12.02b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002788's short term assets (CN¥9.5B) exceed its short term liabilities (CN¥8.2B).
Long Term Liabilities: 002788's short term assets (CN¥9.5B) exceed its long term liabilities (CN¥798.0M).
Debt to Equity History and Analysis
Debt Level: 002788's net debt to equity ratio (147.2%) is considered high.
Reducing Debt: 002788's debt to equity ratio has reduced from 174.2% to 162.3% over the past 5 years.
Debt Coverage: 002788's debt is well covered by operating cash flow (22.1%).
Interest Coverage: 002788's interest payments on its debt are well covered by EBIT (3.2x coverage).